Phase I Study of Immune Ablation and CD34+ Peripheral Blood Stem Cell Support in Patients With Systemic Lupus Erythematosus

Status unconfirmed · Phase 1

Conditions studied: Systemic Lupus Erythematosus

In brief

OBJECTIVES: I. Determine the safety of immune ablation with high-dose cyclophosphamide and anti-thymocyte globulin followed by peripheral blood stem cell support in patients with systemic lupus erythematosus.

Key facts

Study ID

NCT00017641

Run by

Northwestern Memorial Hospital

People needed

10

Starts

2001-04-01

Last updated by the study team

2005-06-24

Who can join

Age: any, up to 59. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Northwestern Memorial Hospital — Chicago, Illinois, United States
• University of Wisconsin Hospital and Clinics — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.